Millan, Febriel Jane B.

HRN: 15-98-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2025
CEFUROXIME 500MG (TAB)
11/29/2025
12/06/2025
PO
500mg
BID X 7 Days
RMLE And Repair
Checking Initial Appropriateness 
11/30/2025
CEFUROXIME 1.5GM (VIAL)
11/30/2025
12/01/2025
IV
1.5 G
Every 8 Hrs
S/P NSVD With RMLE, Inc WBC
Checking Initial Appropriateness 
12/01/2025
CEFUROXIME 500MG (TAB)
12/01/2025
12/08/2025
PO
500 MG
BID
2ND DEGREE RMLE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: